Key factors for best control of the systemic leakage during hyperthermic isolated limb perfusion (HILP) in ECC. A critical synthesis of our experience

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 433-442

  Marcello, Pace ^a   Millanta, L ^a   Gattai, R ^a   Matteini, M ^b   Vaggelli, L ^b   Macera Mascitelli, E ^a   Bechi, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b AOUC   (Italy)

Author keywords

Chemo hyperthermic treatments; Isolated perfusion; Leakage; Limbs tumour

Indexed keywords

HUMAN; HYPERTHERMIC THERAPY; LIMB BLOOD VESSEL; LIMB PERFUSION; LIMB TUMOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMIC CIRCULATION; TOURNIQUET;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTRACORPOREAL CIRCULATION; EXTREMITIES; HUMANS; HYPERTHERMIA, INDUCED; PERFUSION;

EID: 38749119376     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Pace M., Millanta L., Bellacci M., Galli A., Lazzerini S.: Heat administration temperature monitoring and control in hyperthermic - antibalstic perfusion of the limbs. Reg. Cancer Treat. 4: 207-212, 1992.
2. Creech O. jr, Krementz E.T., Ryan R.F., Winblad J.N.: Chemotherapy of cancer: regional perfusion utilizing an extra-corporeal circuit. Ann. Surg. 148(4):616-632, 1958.
3. Pace M., Millanta L., Polignano M., Bini M., Gattai R., Ignesti A., Macera Mascitelli E., Bandettini L., Brugnola D. Perfusione chemo-ipertermica degli arti: una tecnica in continua evoluzione. Tumori 6, S116, 2002.
4. Pace M., Filomena A., Galli A.: Thermal induction and temperature control in the hyperthermic antiblastic regional perfusion with extra-corporeal circulation. Consensus on Hyperthermia for the 1990s. Clinical Practice in Cancer Treatment. Ed.H.I.Bicher et al. Plenum Press, New York, 1990, 399.
5. Noorda E.M., Vrouenraets B.C., Nieweg O.E., van Geel A.N., Eggermont A.M., Kroon B.B.: Prognostic factors for survival after isolated limb perfusion for malignant melanoma. Eur. J. Surg. Oncol. 29(10):916-21, 2003.
6. Pace M., Filomena A., Manetti R., Galli A., Macera Mascitelli E.: Perfusione regionale iper-temico-antiblastica in circolazione extra-corporea nei melanomi degli arti: indicazioni e tecnica. Atti Soc. It. Chir. 90° Congr. I°:367-383, 1988.
7. Pace M.: Optimization of the vascular isolation in isolated regional perfusion of the limbs Reg. Cancer Treat. 3:90-97, 1990.
8. Brizzi E.: Contributo alla conoscenza delle variazioni della vena ipogastrica. Monitore Zoo-logico Italiano 73:91-101, 1965.
9. Kremer K., Lierse W., Platzer W., Schreiber H.W., Weller S.: Grande Atlante di Tecnica Chirurgica - Cranio, Rachide, Bacino. Ed. italiana P. Gallinaro U.T.E.T. 1998, 436-439.
10. Pace M., Brizzi E., Nannelli E., Distante V., Filomena A., Manetti R., Galli A.: Blocco va-scolare temporaneo nella perfusione regionale isolata per neoplasia dell'arto inferiore: studio anatomo-chirurgico delle varianti vascolari. XII Congr. Naz. Soc. It. Ricerche in Chirurgia I:477-479, 1986.
11. Schraffordt Koops H.: Prevention of neural and muscolar lesions during hyperthermic regional perfusion. Surg. Gynecol. Obstet. 135:401-403, 1972.
12. Kroon B.B., Klaase J.M., van Geel B.N., Eggermont A.M., Franklin H.R., van Dongen J.A.: Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb. Eur. J. Cancer. 29A(3):325-8, 1993.
13. Vrouenraets B.C., Eggermont A.M., Klaase J.M., Van Geel B.N., Van Dongen J.A., Kroon B.B.: Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs. Eur. J. Surg. Oncol. 20(6):681-5, 1994.
14. Benckhuijsen C., Kroon B.B.R., Van Geel A.N., Wieberdink J.: Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur. J. Cancer. Clin. Oncol. 14:157-163, 1988.
15. Briele H.A., Djuric M., Jung D.T., Mortell T., Patel M.K., Das Gupta T.K.: Pharmacokintetics of melphalan in clinical isolation perfusion of the extremies. Cancer Res. 45:1885-1889, 1985.
16. Gattai R., Macera Mascitelli M., Millanta L., Polignano M., Bini M., Ignesti A., Pace M.: Computerization and electronic integration in the optimization of biomedical system for the hyperthermic antiblastic perfusion in extracorporeal circulation. In By-Pass 15(1):2043-2046, 2003.
17. Omlor G., Schellhase K.P., Molter G., Menger M.D., Motsch H., Walter P.: Hemodynamics as indications of folow rates during isolated limb perfusion. Reg. Cancer Treat. 3:103-106, 1990.
18. Klaase J.M., Kroon B.B., van Geel A.N., Eggermont A.M., Franklin H.R.: Systemic leakage during isolated limb perfusion for melanoma. Br. J. Surg. 80(9):1124-1126, 1993.
19. Lazzerini S., Millanta L., Olmi R., Pace M.: An analysis of heat supply and temperature distribution in isolated hyperthermic perfusion of the limbs. Phys. Med. 7:135-143, 1991.
20. Pace M., Millanta L., Galli A., Bellacci A.: Closely controlled, highly reproducible and uniform temperature distribution in hyperthermal isolated limb perfusion. Reg. Cancer Treat. 2:94-98, 1994.
21. Pace M., Millanta L., Polignano M., Gattai R., Macera Mascitelli E.: Optimal procedure for thermal delivery in hyperthermic/chemotherapeutic treatments in the isolated perfusion of the the limbs. J. Exp. Clin. Cancer. Res. 24(1):35-42, 2005.
22. Pace M., Galli A., Bellacci A.: Local and systemic toxicity in 'borderline true' hyperthermic isolated perfusion for lower limb melanoma. Melanoma Research 5:371-376, 1995
23. Pace M., Galli A., Bellacci A.: True hyperthermia plus double melphalan bolus in the isolated perfusion for stage III lower limb melanoma. A pilot study. Reg. Cancer Treat. 9:1-7, 1996.
24. Pace M., Galli A., Gattai R., Macera Mascitelli E.: Perfusione isolata dell'arto: stato attuale e prospettive nei pazienti affetti da melanoma. Arch. Atti Soc. It. Chir. 3:196-198, 2000.
25. Benckhuijsen C., Varossieau F.J., Hart A.A., Wieberdink J., Noordhoek J.: Pharmacokinetics of melphalan in isolated perfusion of the limbs. J. Pharmacol. Exp. Then 237(2):583-588, 1986.
26. Pesciullesi A., Bellacci A., Carlà V., Galli A., Nobili S., Mini E., Pace M., Mazzei T.: Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of limbs. Pharmacological Res. 35, 3,323-325, 1997.
27. Pace M., Gattai R., Mascitelli E.: Borderline true hyperthermia (BTH) plus additional L-PAM bolus in the isolated perfusion for stage III lower limb melanoma. Our experience with 93 ILP. Adjuvant Therapy of Malignant Melanoma Stockholm Abstract book. June 2006.